ARS Pharmaceuticals Releases Third Quarter 2024 Financial Results and Business Updates
The Commercial launch of neffy ® (epinephrine nasal spray) in the United States Exciting News for ARS Pharma ARS Pharma is thrilled to announce the commercial launch of neffy ® (epinephrine nasal spray) in the United States. This innovative product is set to revolutionize the way individuals with severe allergies manage their condition. The nasal…